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Abstract
Background: E-mental health has become increasingly popular in interventions for individuals with eating
disorders (EDs). It has the potential to offer low-threshold interventions and guide individuals to the needed care
more promptly. Featback is such an Internet-based intervention and consists of psychoeducation and a fully
automated monitoring and feedback system. Preliminary findings suggest Featback to be (cost-)effective in
reducing ED symptomatology. Additionally, e-mail or chat support by a psychologist did not enhance the
effectiveness of Featback. Support by an expert patient (someone with a lived experience of an ED) might be more
effective, since that person can effectively model healthy behavior and enhance self-efficacy in individuals
struggling with an ED. The present study aims to replicate and build on earlier findings by further investigating the
(cost-)effectiveness of Featback and the added value of expert-patient support.
Methods: The study will be a randomized controlled trial with a two-by-two factorial design with repeated
measures. The four conditions will be (1) Featback, in which participants receive automated feedback on a short
monitoring questionnaire weekly, (2) Featback with weekly e-mail or chat support from an expert patient, (3)
weekly support from an expert patient, and (4) a waiting list. Participants who are 16 years or older and have at
least mild self-reported ED symptoms receive a baseline measure. Subsequently, they are randomized to one of the
four conditions for 8 weeks. Participants will be assessed again post-intervention and at 3, 6, 9, and 12 months
follow-up. The primary outcome measure will be ED psychopathology. Secondary outcome measures are
experienced social support, self-efficacy, symptoms of anxiety and depression, user satisfaction, intervention usage,
and help-seeking attitudes and behaviors.
Discussion: The current study is the first to investigate e-mental health in combination with expert-patient support
for EDs and will add to the optimization of the delivery of Internet-based interventions and expert-patient support.
Trial registration: Netherlands Trial Register, NTR7065. Registered on 7 June 2018.
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Comorbidity, relapse, chronicity, and mortality are com-
mon in eating disorders (EDs), which indicates the serious-
ness of these psychiatric disorders [1, 2]. Unfortunately,
many individuals with EDs do not receive appropriate
healthcare [3]. A study in the Netherlands showed that it
often takes many years to recognize that one is suffering
from an ED and more than 4 years to seek treatment [4].
Explanations for not receiving fitting care seem to range
from geographical and financial reasons to fear of loss of
control, fear of stigmatization, and feelings of shame [5–7].
A simulation study by Moessner and Bauer [8] suggested
that we can most effectively help people with an ED, not by
improving existing treatments or aftercare, but by guiding
them to care more quickly and focusing on prevention.
Additionally, the earlier patients with an ED receive proper
treatment, the higher the chances are for full recovery [9].
Recently, e-mental health (i.e., offering care or treatment
via technological means such as websites, teleconferences,
and smartphone applications) has been proposed as a solu-
tion to bridge this treatment gap that exists for individuals
with an ED. E-mental health has the potential to reduce
barriers to seek help, since it can provide inexpensive, an-
onymous, and easily accessible interventions [9]. Conse-
quently, such low-threshold interventions could help to
improve early detection and intervention of ED problems
and to promptly guide individuals to more intensive care if
needed.
Nevertheless, research regarding the effects of e-mental
health on ED pathology and help-seeking behavior is still
scarce. Results of a recent meta-analytic review [10] dem-
onstrated that Internet-based programs, of which most re-
lied on cognitive behavioral principles, successfully
decreased ED-related symptoms such as body dissatisfac-
tion, symptoms of bulimia nervosa, shape and weight con-
cerns, dietary restriction, and negative affect, and
increased self-esteem and self-efficacy. Two examples of
Internet prevention interventions that have been proven
effective in randomized controlled trials (RCTs) are
Student Bodies [11] and the Body Project [12]. Student
Bodies is a cognitive-behavioral Internet-based program,
including psychoeducation, self-monitoring journals, be-
havioral exercises, and weekly assignments, aimed at im-
proving eating- and body-related issues in people at risk
for developing an ED. The Body Project appeals to the
same group, but it employs a dissonance-based approach,
by letting users critique the thin body ideal in written,
verbal, and behavioral exercises. The strength of such in-
terventions is their ability to reach an underserved popula-
tion. However, they should not be seen as a replacement
for face-to-face treatment, but rather as an addition to the
stepped-care treatment of EDs [9]. Additionally, confi-
dence in results from RCTs regarding e-mental health for
EDs (covering a wide range of interventions but excluding
studies in which the therapist was the primary means of
delivering the intervention) is generally low (often because
of the high risk of bias and inconsistency and the indirect-
ness of and imprecision in outcomes), so more solid
research regarding the form and content of such interven-
tions is needed [13].
Naturally, there are limitations to low-threshold Internet
interventions aimed at prevention and early intervention
of EDs in the extent to which they can respond to the per-
sonal situation of users, especially when compared with
interventions in which intensive and direct contact with a
professional is possible, such as blended care. Neverthe-
less, it is important for low-threshold Internet-based inter-
ventions not to employ a ”one-size-fits-all” approach.
Indeed, not everyone profits from or prefers the same con-
tent of treatment, and the Internet is a highly suitable
medium to convey interventions in a flexible and inter-
active way. The Internet-based program ”Featback” com-
bines prevention and (early) intervention for individuals
with ED symptoms. The program aims to make users
aware of their eating-related and underlying problems.
Users are encouraged to share their problems with their
environment and, for more severe problems, to seek pro-
fessional help. The program can be used anonymously,
reducing the barrier to subscribe. It contains psychoedu-
cation, a fully automated symptom monitoring and feed-
back system, and weekly chat or e-mail contact with a
coach. A more detailed account of Featback is presented
in the “Interventions” section of this article. Featback is
based on ES[S]PRIT [14], a program originally developed
in Germany. Research on ES[S]PRIT suggested the inter-
vention is both feasible [14] and acceptable [15] and
improves self-efficacy in young individuals with ED-re-
lated problems [16] and enhances help-seeking behaviors
[17, 18].
The current research group has performed a first RCT
investigating the effectiveness and cost-effectiveness of
Featback [19]. Featback was offered with or without
chat, Skype, or e-mail support from a therapist, which
resulted in four conditions: (1) Featback only, (2) Feat-
back with weekly support from a therapist, (3) Featback
with support from a therapist three times a week, and
(4) a waiting list control condition when Featback was
complemented with therapist support once or three
times a week. It was found that Featback (with or with-
out support) was more effective in reducing symptoms
of bulimia nervosa (d = − 0.16) and symptoms of anxiety
and depression (d = − 0.31) than the waiting list control
[20]. Contrary to our expectations, no difference in ef-
fectiveness between the active interventions was found.
Regarding the cost-effectiveness, it was found that Feat-
back with or without therapist support represented good
value for the money when compared to a waiting list
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[21], indicating that Featback might be a good alterna-
tive to care as usual, especially for individuals who ex-
perience difficulties in seeking professional help.
Although no added effect on ED psychopathology was
found, Featback users were significantly more satisfied
with the intervention when Featback was complemented
with weekly or three-weekly therapist support. Finally,
moderator analyses showed that Featback was most ef-
fective for individuals with mild to moderate bulimia
nervosa symptoms [22]. The present study aims to fol-
low up and build on these findings by further investigat-
ing the (cost-)effectiveness of Featback and by
investigating the added value of expert-patient support.
Expert-patient support
An explanation of why additional support from a psych-
ologist did not add to the effectiveness of Featback [20]
may be that although individuals suffering from ED symp-
toms appreciate the empathy and support of therapists, it
may not be enough to reduce ED psychopathology. Sup-
port by expert patients (i.e., recovered individuals with a
lived ED experience, also referred to as peers or mentors)
may prove to be more effective for those reluctant to seek
help and in the aftercare for individuals who have com-
pleted treatment and are at risk for relapse [23]. Specific-
ally, expert patients may be more effective in changing
behavior and inspiring hope of recovery, because of a per-
ceived similarity and credibility [23]. The self-evident
credibility of expert patients may make their interventions
more valuable, since reliable [24] and personalized [25]
messages are found to be more effective in changing be-
havior. Additionally, the shared experiences and accom-
panying (perceived) similarity enhances experienced social
support and feelings of closeness [26–30] and various
bonding behaviors [31, 32]. The idea that people who
share a common background or problem have a unique
resource to offer each other appears to be at the heart of
peer support [33]. Relatedly, expert patients are thought
to be effective in enhancing self-efficacy in patients, since
they can powerfully model health behaviors and enhance
patients’ belief in their own capabilities [23, 34, 35], which
is one of the primary goals of Featback. Concordantly, in
the current study it is hypothesized that the credibility
and the shared background of an expert patient and par-
ticipant are sufficient to establish feelings of closeness and
make participants more receptive to interventions aimed
at reducing ED symptomatology and enhancing experi-
enced social support and self-efficacy.
The body of literature on the effectiveness of support
by expert patients is growing. Many studies have investi-
gated expert-patient support for patients with chronic
somatic illnesses in comparison to treatment as usual
and found positive, albeit small, effects on self-efficacy,
self-management, illness-related quality of life, and
worry about the illness [33, 36–41]. Adding expert-pa-
tient support to usual care has also been found cost-ef-
fective for patients with various chronic somatic illnesses
[42]. However, results on the effectiveness of expert-pa-
tient support in mental illness are mixed. For example,
in some studies expert-patient support was associated
with reductions in depressive symptomatology in pa-
tients with major depression and was found to be as ef-
fective as professionally administered treatment and
superior to a waiting list [43, 44]. Furthermore, increases
in self-efficacy were found in patients with severe mental
illness who received expert-patient support in addition
to treatment as usual in comparison to patients who re-
ceived treatment as usual only [45]. On the other hand,
several studies found that adding expert-patient support
to treatment as usual had no significant effect on psy-
chopathology, quality of life, empowerment, or user sat-
isfaction [46]. In addition, the type and objectives of the
expert patient interventions are highly heterogeneous
[47], and confidence in both positive and null findings is
repeatedly low because of the high risk of bias [46]. This
complicates assessment of the value of expert-patient
support for mental illness and warrants further research.
Regarding EDs, currently only a few studies have been
completed [48]. Perez, Kroon van Diest, and Cutts [49]
report that individuals recovering from an ED who are
assigned to an expert patient indicate better relation-
ships, a higher quality of life, and increased intervention
usage than recovering individuals who are not assigned
to an expert patient. Results of two pilot studies are in
line with these findings [50, 51]. However, there were no
active control conditions in these studies. Additionally,
Cardi et al. [52] and Beveridge et al. [53] are currently
conducting trials on the topic of expert-patient support
and EDs. In summary, expert patients may have positive
effects on self-efficacy, belonging, and psychopathology
[48], but findings are currently too circumstantial to
provide convincing proof for the effectiveness of expert-
patient support for EDs or recommendations on its im-
plementation, so further investigation is necessary.
Aims and research questions
The current study builds on the study by Aardoom et al.
[20] by investigating whether the results regarding the
effectiveness of Featback will hold. More specifically, the
first aim is to investigate the (cost-)effectiveness of the
Internet-based intervention Featback in comparison to
Featback with support from an expert patient, support
from an expert patient without Featback, and a waiting
list control condition (WLC). The primary outcome
measures of the current study are ED-related attitudes.
Secondary outcome measures include self-efficacy, social
support, symptoms of depression and anxiety, motiv-
ation to change, user satisfaction, intervention usage,
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and help-seeking attitudes and behaviors. Finally, cost-
effectiveness will be evaluated through the reported
quality of life, outcomes for patients in terms of capabil-
ities, and medical and societal costs. We have two hy-
potheses accompanying the first research aim.
(H1)Our primary hypothesis is that Featback without
expert-patient support, Featback with expert-patient
support, and expert-patient support without
Featback will be more effective in reducing ED
psychopathology and more cost-effective compared
to a waiting list.
(H2)Secondly, we hypothesize that the combination of
expert-patient support plus an online intervention
will be more effective in reducing ED
psychopathology and more cost-effective compared
to expert-patient support or Featback only and that
the improved effectiveness will be maintained up
until a year later.
The second aim of this study is to investigate predictors
and moderators of intervention response to explore what
works for whom. Predictors and moderators that will be
tested as predictors or moderators of treatment response
and/or intervention usage are age, gender, and educational
level, motivation to change, social support, severity of ED
symptoms, severity of symptoms of depression and anx-
iety, self-efficacy, self-esteem, and closeness or perceived
similarity of participants with expert patients. Addition-
ally, self-efficacy is examined as a mediator. Besides the
exploratory tests, there are two hypotheses concerning the
second aim of this study.
(H3)Since a perceived similarity of participants to
expert patients might enhance the receptivity and
self-efficacy of participants, it is hypothesized that
participants who feel more similar to the expert
patient they are assigned to have better outcomes in
terms of ED symptomatology, self-efficacy, and
experienced social support.
(H4)It is hypothesized that, since the effectiveness of
expert patients is theorized to come from effectively
improving self-efficacy, changes in self-efficacy
during the intervention period mediate subsequent
long-term effects of the intervention on ED-related
symptoms and experienced social support.
Thirdly, we aim to investigate practical experiences with
Featback, such as intervention usage and user satisfaction.
(H5)It is expected that Featback with weekly expert-
patient support will enhance intervention usage as




Since the present study is a continuation of previous work
of this research group, the methodology described here
will be similar and in some parts identical to the previous
design [19]. The current study describes an RCT with a
two-by-two factorial design with repeated measures to
create four different conditions: (1) Featback, comprising
psychoeducation and a fully automated self-monitoring
and feedback system, (2) Featback with weekly individual-
ized support by an expert patient through e-mail or chat,
(3) weekly individualized support by an expert patient
through e-mail or chat, and (4) a waiting list. A descrip-
tion of the content of the interventions for each condition
is presented below. After screening, all eligible participants
are asked to give informed consent and fill in online base-
line measures (T0). Subsequently, they will be randomized
to one of the four conditions. An independent researcher
will conduct randomized allocation by using the SPSS
function to produce random numbers. Hence, the main
researcher will be blind to the randomization process.
Randomization will take place in blocks of 40 participants.
The current design does not allow expert patients to be
blinded to the study goal, since they are required to help
participants with their ED or ED-related problems to the
best of their abilities within the intervention protocol. Nat-
urally, expert patients know that the individuals they have
contact with via e-mail or chat are randomized to one of
the expert-patient support conditions. Similarly, partici-
pants are not blinded concerning the condition allocation.
After 8 weeks (intervention period or waiting period),
participants are invited to complete the post-interven-
tion assessment (T1). Finally, a link to the online follow-
up questionnaires will be sent to them 3 (T2), 6 (T3), 9
(T4), and 12 (T5) months after T1 (see Fig. 1). Ethical
approval has been obtained by an independent medical
ethics committee (CME LUMC Leiden, file number
NL64553.058.18). The Standard Protocol Items: Recom-
mendations for Interventional Trials (SPIRIT) checklist
is provided as Additional file 1.
Participants
The study sample will be recruited via the Dutch e-com-
munity ”Proud2Bme” (http://www.proud2bme.nl), via
the Featback website and the network of the patient
organization WEET. Proud2Bme is an interactive web-
site that is designed for young people or adolescents
(mainly girls) with eating problems or an ED. It is a
healthy alternative to many pro-anorexia websites and
promotes a healthy lifestyle and positive self-image. Eli-
gible participants are aged 16 years or older, have access
to the Internet, have self-reported ED symptoms defined
as scoring 52 or higher on the Weight Concerns Scale
(WCS) [54], or report one or more of the following ED
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symptoms assessed by the Short Evaluation of Eating
Disorders (SEED [55]): a body mass index (BMI) lower
than or equal to 18.5, one or more binge eating episodes
a week over the past 4 weeks, or one or more compensa-
tory behaviors a week over the past 4 weeks. Participants
are excluded if they are younger than 16 years or do not
report any ED symptoms. Otherwise, there are no exclu-
sion criteria, since both people with beginning and se-
vere eating problems may benefit from Featback and/or
expert-patient support (see also the “Ethical consider-
ations” section of this article).
Interventions
Featback
All participants in the Featback conditions can access
the Featback website on which comprehensive informa-
tion on EDs and their causes and consequences can be
found (i.e., psychoeducation). The psychoeducation will
be purely self-guided, meaning that participants are free
to choose what to read and when. For the monitoring
and feedback system, participants receive an invitation
by e-mail to complete a monitoring assessment weekly.
This questionnaire consists of four 4-point Likert items
assessing ED-related behaviors, namely (1) excessive
concerns with body weight and shape, (2) unbalanced
nutrition and dieting, (3) binge eating, and (4) compen-
satory behaviors. When participants have completed the
questionnaire, a supportive feedback message will be
automatically generated according to a pre-defined algo-
rithm, which addresses their reported behaviors (healthy
or unhealthy range) and patterns of change (improved,
deteriorated, or unchanged) on each of the assessed ED-
related behaviors. Hence, the automated messages vary
in content depending on the problems that users report.
The messages contain a summary of self-reported eating
problems, psychoeducation, and guidance on how to
counter ED-related symptoms, which are formulated in
a supportive and reinforcing way. Table 1 illustrates one
of these automatically generated messages.
Weekly expert-patient support
All recruited expert patients (N = 5) have participated in
an intensive day of training. The first part of the training
comprised how to use the experience of having had and
overcoming an ED to help others struggling with ED-re-
lated problems. The second part comprised an elaborate
explanation of the research and the Featback program.
Subsequently, a training specifically focused on the deliv-
ery of online support via chat and e-mail was delivered.
An intervention protocol was handed out and explained
to the expert-patient support team. The protocol includes
guidelines about how to provide support so that all expert
patients will work from a similar perspective and with
similar methods. The five-phase model on which the
intervention is based contains (1) warm welcome, (2) clar-
ify the question, (3) determine the goal of the conversa-
tion, (4) elaborate on the goal of the conversation, and (5)
close the circle. The phases of e-mail support are (1) ex-
tract the question, (2) formulate an answer, and (3) check
and send the message. More detailed information on the
models for e-mail and chat support can be found in the
handbook written by Schalken et al. [56]. The expert-pa-
tient supporters have practiced with offering chat and e-
mail support during and after the training, and feedback
Fig. 1 Flowchart of study procedures
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on their practice sessions was provided by an expert pa-
tient and experienced psychologist. Participating expert
patients will receive monthly supervision during the study
by an experienced expert patient and clinical psychologist
to ensure high-quality and ethically correct support. They
have a set amount of hours per week that they can flexibly
distribute, and they receive monthly payment for worked
hours on the project.
Participants can schedule a weekly appointment with
an expert patient. For each session, participants can
choose to receive support via chat or e-mail. Chat ses-
sions have a duration of 20 min, and for e-mail support
participants are required to send an e-mail before the
scheduled appointment to which an expert patient will
reply at the time of the appointment.
Waiting list control
Participants will be placed on a waiting list for 14
months (matching the participation duration of partici-
pants in the other conditions; 8-week intervention
period plus 1 year follow-up), after which they will be of-
fered 8 weeks of Featback with support from an expert
patient. Participants in this condition will be asked to
complete the same assessements as participants in the
other conditions (i.e., T0-T5). Note that participants in
all conditions are allowed to seek and receive treatment
and take medication.
Intervention check
To assess the difference between support by expert pa-
tients and psychologists, a formal integrity check will be
conducted. After data collection, 15 randomly selected
chat and 15 e-mail sessions of expert patients will be
compared to 15 randomly selected chat and 15 e-mail
sessions of psychologists respectively (taken from the
previous RCT of this research group; 20). Subsequently,
three independent master level psychology students,
blind to the source of the e-mail or chat session, will rate
the 60 sessions with the integrity list. Expert patients
and psychologists collaborated to create the integrity
checklist, which involves (1) the structure of the session,
(2) the content/interventions used during the session,
and (3) the way in which these interventions were con-
veyed (see Additional file 2). We expect that the struc-
ture of an e-mail or chat is similar between expert
patients and psychologists, since the same structuring
methodology is used. However, psychologists are ex-
pected to use a broader pallet of interventions (i.e., more
distinct interventions) during the e-mail and chat sup-
port. Lastly, the most noticeable difference is expected
in the way in which interventions are conveyed. More
specifically, it is hypothesized that expert patients will
explicitly mention their own experiences during every e-
mail or chat session to try to change attitudes or behav-
iors of participants, whereas psychologists will never do
this. Additionally, expert patients are expected to use
fewer medical terms or abbreviations in their e-mail or
chat sessions than psychologists.
Measures
Table 2 presents an overview of the assessment instru-
ments used for each measurement time. Estimated
times (minutes) to complete each questionnaire are pre-
sented in parentheses. Details of the instruments are de-
scribed in the following sections.
Screening measures
Weight Concerns Scale The Weight Concerns Scale
(WCS [54]) is a five-item questionnaire used to evaluate
the eligibility of participants. The five items are derived
from a principal component analysis of a list of ques-
tions used to measure ED symptoms [54] and assess the
extent to which participants struggle with their weight,
Table 1 Example of an automatically generated Featback message. Note: This message reflects the content when a participant
indicates in the weekly monitoring that she or he worries about food, has at least one day in which she or he restricts food intake,
and has had more binges and compensation behavior than in the previous week. The message is translated freely from the Dutch
version
“We are concerned about your eating problems. You indicate that last week you have been worrying about food and your body, you have not eaten
sufficiently every day and have had more days on which you dealt with binges and compensatory behaviors. That’s no small thing you’re dealing
with :(.
The urge to eat can emerge from stress, tension and/or emotions that suddenly occur. Is that something you recognize? Do one or more of these
factors also precede a binge for you? It is possible to directly respond to these tensions or emotions by giving in to your binge. However, in fact you
are not really heeding them, but you are muffling or dampening them and putting them aside. This mostly has a reversed effect, since not only do
these tensions and emotions return at a later time, you generally feel worse after a binge as well.
Next time you feel an urge to binge or compensate your food, try to delay it. You will notice that after a while the binge or compensating behavior
seems less necessary, or even not necessary at all! For this week, try to delay the urge for about 10 minutes. Also think about activities you can
undertake during those 10 minutes to make delaying your binge or compensating behavior more bearable. Call a friend, put on your favorite music,
go on a stroll through town or find another activity. Did you achieve the 10-minute delay? Excellent! Challenge yourself to extent the time you set
for yourself every now and then.
Will you rise to the challenge? We are very curious to see what will happen when you learn to delay your harmful eating behaviors and whether this
will help you. Good luck!”
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Table 2 Overview of assessment occasions and their content
Note: The Inclusion of Other in the Self scale (IOS scale; 0.5 min to complete) will be sent at week 3 of the intervention for all participants in a condition with
expert-patient support. Attrition follow-up questions will be sent only to participants who do not respond to the assessments
FU follow-up, WCS Weight Concerns Scale, SEED Short Evaluation of Eating Disorders, PHQ-4 Patient Health Questionnaire, EDE-Q Eating Disorder Examination
Questionnaire, GSES General Self-Efficacy Scale, SSL Social Support List, RSES Rosenberg Self-Esteem Scale, EQ-5D-5 L EuroQol five dimensions, five levels generic
health index, ICECAP-A ICEpop CAPability measure for Adults, TiC-P MIDI Trimbos/iMTA questionnaire for Costs associated with Psychiatric Illness Midi version,
PCQ Productivity Costs Questionnaire
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eating pattern, shape, and perceived corpulence. Test-re-
test reliability and predictive validity have been investi-
gated and demonstrated for the WCS [57]. Furthermore,
the WCS has been found to be able to predict students
at risk for developing an ED [58].
Short Evaluation of Eating Disorders The Short Evalu-
ation of Eating Disorders (SEED [55]) contains six self-
report questions designed to quickly assess the key ED
symptoms. Participants are asked to evaluate their own
body on several dimensions (e.g., thinness, attractiveness,
and muscularity) and to report the frequency of several
ED-related behaviors, such as self-induced vomiting, use
of laxatives, and binge eating, over the last 4 weeks.
Items are presented on a 5-point Likert scale. Summing
the items of the two separate diagnoses leads to a sever-
ity index (range 0–3), with higher scores indicating
higher severity. The SEED has been found to have good
construct and criterion validity and was demonstrated to
be sensitive to symptom change [55].
Primary outcome measures
The primary outcome measures involve the Eating Dis-
order Examination Questionnaire (EDE-Q [59]), which
will be used to assess ED symptomatology. The EDE-Q
has 28 items and assesses both the frequency of core ED
behaviors (6 items) and ED-related attitudes (22 items)
over the past 28 days. Items assessing the ED-related at-
titudes are presented on a 7-point Likert scale (range 0
”not at all” to 6 ”every day/markedly”) and include ques-
tions regarding weight, shape, and eating concerns and
restraint. A global ED psychopathology score will be cal-
culated by summing and averaging the 22 items. Higher
scores indicate higher ED psychopathology. Internal
consistency, test-retest reliability, and discriminative val-
idity of the EDE-Q have been found to be acceptable to
high [60].
Secondary outcome measures
General Self-Efficacy Scale The General Self-Efficacy
Scale (GSES [61]) is a 10-item psychometric scale de-
signed to measure a general sense of perceived self-effi-
cacy with the aim to predict coping with daily hassles
and adaptation after experiencing various stressful life
events. The questionnaire has been used in many studies
with numerous participants [62]. Responses are recorded
on a 4-point scale. The individual items are summed to
produce the final composite score with a range of 10 to
40. In samples from 25 nations (including the
Netherlands), Cronbach’s α ranged from 0.75 to 0.91,
with most values over 0.80. Psychometric properties of the
GSES are adequate [63]. The scale is one dimensional and
designed for the general adult population, including
adolescents.
Social Support List Perceived social support is mea-
sured with the short version of the Social Support List
Interaction (SSL-12-I [64]). This self-report question-
naire measures the extent to which a participant experi-
ences social support. The SSL-12-I contains 12 items in
three scales, namely (1) everyday social support, (2) sup-
port in problem situations, and (3) esteem support (i.e.,
support resulting in self-esteem). Items (starting with
”Does it ever happen that people…” and ending with
statements like ”…comfort you?” or ”…give you good ad-
vice?”) are presented on a 4-point scale ranging from
”hardly or never” to ”very often”. Scores range from 12
to 48, and higher scores are indicative of more experi-
enced social support. Psychometric properties are dem-
onstrated to be good [64, 65].
Patient Health Questionnaire The Patient Health
Questionnaire (PHQ-4 [66]) measures symptoms of de-
pression and anxiety. It consists of two primary anxiety
items and two primary depression items. The anxiety
and depression subscales have been found to reflect two
separate dimensions [66]. The four items are presented
on a 4-point Likert scale ranging from 0 ”not at all” to 3
”nearly every day”. By summing all items, a composite
score (range 0–12) can be calculated. Higher scores indi-
cate higher pathology. The PHQ-4 has been demon-
strated to possess factorial and construct validity [66].
Motivation to change Three items will be used to as-
sess participants’ motivation to change [67, 68]. The first
item assesses the perceived importance to change of par-
ticipants (On a scale of 1 to 10, how important is it for
you to change?). The second item assesses the ability or
confidence to change (On a scale of 1 to 10, how
confident are you that you could make a change if you
wanted to?). The third item assesses one’s readiness to
change (On a scale of 1 to 10, how ready, or how pre-
pared are you to change? Are you not prepared to
change, already changing, or somewhere in the middle?).
User satisfaction To assess the user satisfaction of Feat-
back, a questionnaire was developed. Among other ques-
tions, participants are asked how they rate the quality of
support they have received from Featback, whether Feat-
back helped them to more effectively cope with their
eating-related problems, and the extent to which they
were satisfied with Featback in general. Additionally,
participants are requested to rate the various compo-
nents of Featback and address positive points as well as
points for improvement (e.g., they are asked what they
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liked or disliked most and how the intervention can be
developed further).
Help-seeking attitudes and behavior questionnaire A
custom-made questionnaire was developed to assess
help-seeking attitudes and behaviors. Participants are
presented with three 7-point Likert scale questions (ran-
ging from 0 ”not at all applicable” to 6 ”fully applicable”)
concerning the extent to which they believe professional
help is useful, they need professional help themselves, and
they know where to find help. Furthermore, intention to
seek professional help and actual help-seeking behavior
are assessed, and the extent to which Featback contributed
to these processes is inquired. Depending on whether the
participant has sought help or not, the number of ques-
tions in this section ranges from three to five; they are ei-
ther open or yes-no questions. Finally, participants are
inquired as to the frequency of visiting websites other than
Featback in relation to their (eating) problems, visiting
and/or using a forum, or making use of online support
service in relation to their (eating) problems.
Intervention usage Intervention usage will be opera-
tionalized by the amount of weekly monitoring assess-
ments a participant has completed during the
intervention period (range 0–8). Additionally, to be able
to further investigate the relation between intervention
usage and the effectiveness of Featback, the number of
received support sessions of participants (one for each
received e-mail or chat session) will be recorded.
Cost-effectiveness measures
General quality of life The EuroQol five dimensions,
five levels generic health index (EQ-5D-5 L [69]) is a stan-
dardized self-report questionnaire consisting of five di-
mensions (mobility, self-care, usual activities, pain/
discomfort, and anxiety/depression). Participants rate each
dimension on five levels (ranging from ”no problems” to
”extreme problems”). Consequently, 243 distinct health
states are defined, each with a unique utility score, ranging
from 1 (perfect health) to 0 (death). The health descrip-
tions will be linked to empirical valuations of the Dutch
general public, allowing utilities to be computed [70].
While the EQ-5D-5 L is the gold standard for comput-
ing utilities and economic evaluations, it is limited in the
sense that it mainly addresses physical aspects of the
health experience and might not be appropriate for
assessing mental health problems. For example, psychi-
atric patients may not endure many physical problems
while still experiencing considerable distress. Ap-
proaching outcomes for individuals by focusing on peo-
ple’s capabilities, instead of physical aspects of health,
might therefore be more suitable for individuals with
psychiatric conditions [71]. The ICEpop CAPability
measure for Adults (ICECAP-A [72]) shows promise in
going beyond the general health status and capturing
broader outcomes for individuals. The questionnaire
aims to measure five capabilities on a 4-point scale,
namely stability (the extent to which someone feels
consistency and safety in life), attachment (the extent to
which someone feels love, friendship, and support in life),
autonomy (the extent to which someone can be independ-
ent in life), achievement (the extent to which someone
can make progress in life), and enjoyment (the extent to
which someone can enjoy life). The five items attempt to
capture an individual’s capability to live a life that he/she
values. The ICECAP-A has been found to be a valid meas-
ure of one’s capabilities [73] and appears to be suitable for
economic evaluation of outcomes of adults with mental
health problems, such as depression [71].
Direct medical costs The Trimbos/iMTA questionnaire
for Costs associated with Psychiatric Illness (TiC-P, Midi
version [74]) will be used to calculate the total direct
medical costs. The TiC-P assesses medical treatment
utilization (e.g., number of contacts with the general
practitioner, medical specialists, and paramedics) and
medication use during the last 3 months. Additionally,
the Midi version of the questionnaire is significantly
shorter, reducing the burden for participants, while
retaining 90% of the total cost estimated by the full ver-
sion [74]. The direct medical costs will be calculated
using the Dutch guidelines for cost calculations in
healthcare [75]. Reference unit prices of the correspond-
ing health care services will be applied [75, 76].
Demographics, closeness, self-esteem, and attrition
Demographic A self-designed questionnaire will be used
to gather demographic information. More specifically,
gender, age, educational level, country of origin, and work
situation will be assessed. Three additional questions are
included, to inform about Internet access, the severity of
eating problems, and whether participants have previously
been or are currently in treatment for an ED.
Inclusion of Other in the Self scale The Inclusion of
Other in the Self scale (IOS scale [77]) will be sent to
participants allocated to one of the conditions with sup-
port by an expert patient at week 3 of the intervention
to assess perceived similarity and feelings of closeness
early in the working relationship between expert patient
and participant. The IOS scale is a one-item instrument
in which seven images with two circles representing the
self and the other that overlap increasingly, from zero
overlap to almost complete overlap, are presented to
participants. The participants can then rate their
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relationship with another person by choosing the best
fitting image. More overlap between the circles indicates
a closer bond. This scale is particularly suited for the
current study, since it can be used for any type of rela-
tionship, and not only romantic partners, friends, and
acquaintances [78]. Furthermore, Gächter, Starmer, and
Tufano [79] conducted three studies to examine the val-
idity and reliability of the IOS scale. A very strong con-
vergent validity with a closeness index derived from six
other relationship inventories (Spearman correlation of
0.85) was found. The authors conclude that the one-item
IOS scale is easy to use, highly reliable, and a very
powerful measure of closeness of relationships.
Rosenberg Self-Esteem Scale The Rosenberg Self-Es-
teem Scale (RSES [80]) is the most used measure of glo-
bal self-esteem. It consists of 10 items measuring the
affective evaluation of the self. The items are presented
on a 4-point scale ranging from ”totally agree” to ”totally
disagree”. The questionnaire has been found to have sat-
isfactory psychometric properties [81]. The Dutch trans-
lation of the RSES originates from Franck, De Raedt,
Barbez, and Rosseel [82], who created the translation
using forward and back translation methods. Two stud-
ies indicate high internal consistency and good conver-
gent and divergent validity of the Dutch version of the
RSES [82, 83].
Attrition follow-up Attrition can refer to participants
no longer using the intervention (non-usage attrition) or
to participants completely dropping out of the study
(dropout attrition). Two questions were designed to in-
vestigate why people dropped out of the study or no lon-
ger used the intervention to which they were allocated.
If a participant fails to complete a monitoring assess-
ment, an e-mail with a reminder will be sent. A week
later, participants receive another reminder. This re-
minder includes a question asking whether one wishes
to continue Featback or not, and, if not, participants are
asked to answer one more question by writing down
their reason(s) to quit the intervention (i.e., attrition fol-
low-up question).
If a participant fails to complete a T1, T2, T3, T4, or
T5 assessment within 1 week, an e-mail with a reminder
will be sent. A week later, a second reminder will be
sent. This reminder includes a question asking whether
one wishes to further participate in our study, and, if
not, participants are asked to answer one more question
by writing down their reason(s) to quit the study.
Participant procedures
Figure 1 depicts an overview of the procedures that par-
ticipants will undergo throughout the study. After re-
cruitment, interested individuals can send an e-mail to
the main researcher. Consequently, they will be sent a
reply in which they are thanked for their interest and in-
vited to complete a screening questionnaire. Participants
who complete the screening questionnaire receive an e-
mail including feedback on their results and a notifica-
tion about whether or not they are considered eligible
for the study.
Participants who are eligible for the study will be sent
an e-mail which contains an explanation of the study
and corresponding procedures. Participants then have to
give their informed consent to continue with the study.
Agreeing to the terms of participation will be possible
through clicking several checkboxes. Because informed
consent is given online, the system will generate a pop-
up at the end of the form with a question asking partici-
pants are sure they give consent to participate in the
study. Here, participants will also be notified that they
can leave the study at any time for any reason if they
wish to do so, without any consequences. Subsequently,
participants are presented with a link to the first assess-
ment (T0). After giving informed consent and filling in
the baseline measurement, participants will be random-
ized to one of the four conditions and will receive an e-
mail about the condition to which they are allocated and
the corresponding procedures.
At this point, the 8-week period of intervention (or
waiting) starts. At post-intervention (T1, week 8) and
for all follow-up measurements (T2, 3 months; T3, 6
months; T4, 9 months; T5, 12 months) participants
will be asked to complete the corresponding question-
naires. Finally, participants will receive an e-mail in
which they are thanked for participating in the study.
Participants who take part in the study receive 10
euros as compensation in the form of a gift voucher
after the last measurement. Additionally, participating
in the study will be made more personal and reward-
ing in the form of an e-mail sent to participants after
every T1–T5 assessment, in which gratitude for par-
ticipation is expressed. Hopefully, these incentives
increase intervention usage and reduce attrition in the
study.
Ethical considerations
Participants will be asked to complete questionnaires at
baseline, a weekly monitoring questionnaire during the
intervention, and a three-monthly questionnaire during
the follow-up phase. This has been found to be an ac-
ceptable burden by a client panel. Earlier research with a
comparable design showed no adverse effects of Feat-
back [20], and participants in all conditions, including
the waiting list, are allowed to seek treatment outside
the study.
Individuals who enter the study and report severe ED
symptoms during the screening or who develop severe
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ED symptoms during the intervention will be sent an e-
mail stating that their scores indicate serious ED prob-
lems and that professional help is warranted. More spe-
cifically, if a participant indicates a BMI of 15 or lower
or reports compensatory behavior or bingeing at least
every day during a week in the screening or Featback
monitoring assessment, an alarm signal will be sent to
the main researcher. If the participant is allocated to the
Featback only or waiting list control condition, the par-
ticipant will be sent an e-mail in which the researchers’
concerns about the severe ED symptoms are expressed
and recommendations for professional help are included.
If the participant is allocated to one of the expert-patient
support conditions and the participant has not scheduled
an appointment for this week, an e-mail will be sent to en-
courage the participant to schedule an appointment. Dur-
ing the support session, the expert patient will discuss the
alarm signal and severe ED symptoms and stimulate the
participant to seek professional help. Similarly, partici-
pants in the support only condition who indicate (increas-
ingly) severe problems in their chats or mails will be
encouraged to seek professional help in subsequent ses-
sions. If participants with severe ED symptoms do not
make an appointment for a support session, the e-mail as
described for participants in the Featback only or waiting
list control condition will be sent.
Nevertheless, individuals with severe ED symptoms
will not be excluded from the study, as there is no rea-
son to withhold Featback or expert-patient support. It
could well be that these individuals are reluctant to seek
(face-to-face) treatment or that they are not fully aware
of the severity of their symptoms. Accordingly, Featback
may serve as an important first step to regular health-
care, because it could help individuals with the process
of recognition and acknowledgement of the severity of
their ED symptoms and the need to seek professional
help (see also [18]). Moreover, Featback and/or the
individualized support from expert patients may serve as
an important and unique source of support that could
help individuals deal with their (eating) problems more
effectively.
Expert patients are instructed to refer participants who
report suicidal ideation to the website of ”Stichting 113”
[84]. The goal of this organization is to prevent suicide.
They have psychologists, psychiatrists, and trained vol-
unteers in employment who are accessible 24 h a day via
telephone and chat.
Sample size calculation
An a priori statistical power analysis was conducted in
G*Power version 3.1 to determine the optimal sample
size having 80% power to detect a small effect size (f =
0.15, which corresponds to d = 0.30) between the active
intervention conditions on the one hand and the control
condition on the other. Consequently, the sample size
calculation was based on a between-factors repeated
measures analysis of variance (ANOVA) with two groups
and two measurements (i.e., baseline and post-interven-
tion; T0–T1). A significance level of α = 0.05 was main-
tained. The effect size was based on data from a
previous RCT [20]. Calculations indicated a total of 264
participants will be needed, meaning 88 participants per
condition. We assume a Pearson correlation of 0.5 be-
tween the outcome variable on baseline and post-inter-
vention (i.e., T0–T1), which explains 25% of the variance
of the outcome variable. Therefore, the sample size per
group can be reduced by 25%. However, adjusting for an
anticipated dropout rate between T0 and T1 of 25%
(based on previous data), we will still need 88 partici-
pants per condition (N = 352). The high dropout rate
introduces a risk of bias through selective dropout. How-
ever, participants in the previous Featback trial [20] who
dropped out during the intervention did not differ from
those who did not drop out with regard to ED psycho-
pathology, ED quality of life, comorbid anxiety or
depression, age, weight, hours spent online, allocated
condition, and duration of their eating problems. Hence,
bias because of selective dropout in the current sample
is, at least based on these variables, improbable.
Statistical analyses
All statistical analyses will be conducted in SPSS ver-
sion 25 and the R statistical programming environ-
ment [85]. A two-tailed significance level of α = .05
will be maintained throughout the analyses unless in-
dicated otherwise. All analyses will be conducted
according to the intention-to-treat (ITT) approach.
This means that all participants who underwent
randomization, even those who withdrew from the
study or deviated from the protocol, are included in
the analyses. For the effectiveness analyses, both ITT
and completers analyses will be conducted. A partici-
pant is considered a completer when he/she has
completed at least five monitoring assessments (i.e.,
Featback only condition), five support sessions (i.e.,
expert-patient support only condition), or both (i.e.,
Featback plus expert-patient support condition).
Missing data will be handled using multiple imputation
[86]. Multiple imputations using predictive mean match-
ing will be conducted in the statistical programming
environment R [85]. Interactions will be taken into ac-
count in the imputation procedure [87]. Multiple imput-
ation methods have several advantages over complete-case
analyses or single imputation techniques and are therefore
highly recommended [86, 88].
Homogeneity of groups (i.e., between-group differ-
ences) will be assessed at baseline (T0) using chi-square
tests for categorical variables and ANOVAs for
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continuous variables. Additionally, homogeneity of vari-
ances will be assessed using Levene’s statistic, and non-
parametric testing will be used when appropriate.
Intervention effectiveness analyses
To investigate the effectiveness of Featback with and
without weekly expert-patient support, within-group and
between-group effect sizes (Cohen’s d) will be calculated
(i.e., the effects of time and intervention) using the
pooled standard deviation of each group. We are mainly
interested in the effect from baseline to post-interven-
tion (T0–T1), but to see if effects are maintained over
the short and long term, analyses will be repeated for
T1–T3 and T1–T5 respectively.
(H1)To answer the first and main hypothesis that the
active interventions (i.e., Featback, expert-patient
support, and Featback plus expert-patient support)
are more effective than a waiting list in reducing
ED symptomatology (i.e., primary outcome EDE-Q
global score), the three active intervention
conditions will be compared to the waiting list
condition. Repeated measures ANOVA will be used
for T0–T1 to test this hypothesis. To see if the
effects are maintained, these analyses are repeated
for T1–T3 and T1–T5.
(H2)The second hypothesis was that the combination
of Featback and expert-patient support would be
more effective than Featback or expert-patient
support alone. A repeated measures ANOVA with
post hoc tests will be conducted to compare T0–T1
differences in ED symptomatology between the four
conditions. The post hoc analyses apply the
Bonferroni correction for multiple testing. To see if
these effects are maintained, these analyses are
repeated for T1–T3 and T1–T5.
These confirmatory analyses will be repeated con-
trolling for significant baseline variables (i.e., age,
duration of ED psychopathology, number of psycho-
logical healthcare appointments). Additionally, the
main analyses will be repeated for completers only.
Moderator and mediator analyses
Potential moderators of treatment effects will be investi-
gated using model-based recursive partitioning methods
[89]. Model-based recursive partitioning can be used to
detect what are called treatment-subgroup interactions.
Treatment-subgroup interactions occur when subgroups
of patients show differences in the effectiveness (i.e., a
better or worse outcome) of one or more interventions.
Model-based recursive partitioning can be used to iden-
tify these subgroups and their characteristics [90, 91]
and ultimately help to tailor treatment to individual
patients. These analyses will be explorative in nature and
will apply the conservative Bonferroni correction for
multiple testing.
(H3)The third hypothesis concerned the relationship
between the closeness or perceived similarity of
participants with the expert patient they are
assigned to, and ED symptomatology, self-efficacy,
and experienced social support respectively. The
effects of perceived similarity on the three
dependent variables will be investigated for the
short term (i.e., gains until post-intervention, T1)
and the long term (i.e., gains until the last follow-
up, T5), resulting in six linear regression analyses
that need to be conducted. We correct for multiple
testing for these analyses using Holm’s method.
(H4)To investigate the fourth hypothesis that changes
in self-efficacy during the 8-week intervention
period mediate subsequent changes in ED-related
symptoms and experienced social support (and not
vice versa), a cross-lagged panel design will be used.
For self-efficacy and the two outcome variables,
change scores will be calculated for pre- (T0) to
post-intervention (T1) and for post-intervention
(T1) to long-term follow-up (T5; 12 months after
T1). Next, hierarchical regressions will be
performed, with post-intervention to long-term
follow-up change of ED-related symptoms and
experienced social support as dependent variables,
and pre- to post-intervention change of self-efficacy
as the independent variable. Additionally, the
inverse relationships will be investigated. In other
words, it will be examined whether changes in
experienced social support or ED-related symptoms
from pre- to post-intervention can predict post-
intervention to long-term follow-up changes of self-
efficacy. If the initial relationship is significant and
the inverse relationship is not, a mediation effect of
self-efficacy on ED-related symptoms and/or
experienced social support is indicated. Corrections
for autocorrelation and synchronous change will be
applied to the mediation analysis.
Satisfaction and intervention usage analyses
(H5)To examine the fifth hypothesis that Featback with
weekly expert-patient support results in an
increased satisfaction and intervention usage, an
ANOVA will be conducted to compare mean
scores of satisfaction and intervention usage at T1
(i.e., directly after the intervention) between the
three active intervention conditions. We correct for
multiple testing for these analyses using Holm’s
method.
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Cost-effectiveness analyses
The effects and costs of Featback and/or online support
from an expert patient will be compared to those of usual
care (i.e., participants in the waiting list condition) from a
societal perspective, including healthcare costs and non-
healthcare costs. No discounting will be applied due to the
time horizon of the economic evaluation of 1 year.
The effects of an intervention will be assessed with the
EQ-5D-5 L at baseline and subsequent follow-up mea-
surements. The EQ-5D-5 L results will be translated into
utilities using the EQ-5D-5 L with Dutch rates [92]. The
quality-adjusted life year (QALY) outcome per patient
will be obtained by using the area-under-the-curve
method for the utility scores obtained for each patient.
Outcomes of patients in terms of capabilities instead
of QALYs will also be calculated using the ICECAP-A
by means of the UK general population tariff (no Dutch
tariff is available) [93], since results from this instrument
might reflect outcomes of psychiatric patients better
than the EQ-5D-5 L results [71].
The costs will be divided into healthcare costs and
non-healthcare costs. Healthcare costs are calculated by
summing the costs of Featback and/or online support
from an expert patient, and other healthcare use during
the first year of follow-up. Intervention costs of Featback
include the maintenance of the program and website
and payment to a psychologist following the procedure
when a user develops severe ED pathology while using
Featback. Intervention costs of expert-patient support
are estimated by multiplying the time spent on sessions
by their hourly pay rate. Costs for supervision of expert
patients are also included, by multiplying the time spent
at supervision by their hourly pay. Healthcare use is
assessed with the TiC-P Midi [74], which records the
number of contacts with care providers and use of medi-
cation during the last months (i.e., the period between
every follow-up measurement). The costs will be calcu-
lated by multiplying the number of contacts with a
specific healthcare provider by the reference unit price
of the corresponding healthcare service [75, 76]. Add-
itionally, non-healthcare costs, including costs related to
productivity losses at work through being absent or be-
ing less productive and having difficulties in performing
unpaid work such as domestic tasks, are estimated. Costs
related to absenteeism will be calculated according to
the friction cost method, which means that the absent
hours are multiplied by the average gross hourly wage
per paid working individual in the Netherlands with a
maximum of 12 weeks, the friction period in the
Netherlands [75, 76]. The friction period is the timespan
organizations need to restore the initial production level
[94]. Costs related to reduced efficiency at work are cal-
culated based on the amount of hours of work partici-
pants estimate they need in order to catch up for all the
work they were unable to perform because of health
problems. These hours are again multiplied by the aver-
age gross hourly wage per paid working individual in the
Netherlands, based on age and gender. Costs related to
difficulties in performing unpaid work are calculated by
multiplying the amount of hours that others would need
to take over the unpaid work of the participant by the
average gross hourly wage of a domestic worker. In sum-
mary, total costs of an intervention can be estimated by
summing the healthcare costs (including the interven-
tion costs) and non-healthcare costs consisting of prod-
uctivity costs (including absenteeism, reduced efficiency
at work, and difficulties performing unpaid work).
Differences in mean costs and effects per patient be-
tween interventions will be compared using a two-sided
t test. The uncertainty regarding mean costs and effects
per participant will be estimated using bootstrapping in
Microsoft Excel, simulating 1000 bootstrap samples.
Specifically, 1000 samples will be drawn from the ori-
ginal sample to estimate the sampling distribution and
its 95% confidence interval. The results of the bootstrap-
ping will be represented in cost-utility acceptability
curves. These curves illustrate the probability that an
intervention (i.e., Featback) is cost-effective in compari-
son with the alternative (i.e., care as usual) for a range of
ceiling ratios, which are the maximum amount of costs a
society is willing to pay for one unit change in outcome
(i.e., QALY).
Data management
Data of participants will be handled and saved strictly
confidentially according to the enforced laws and regula-
tions, including the EU General Data Protection Regula-
tion (GDPR) and the Declaration of Helsinki – 64th
WMA General Assembly, Fortaleza, Brazil, October
2013. Data obtained from participants will be, among
others, e-mail address, age, level of education, and data
about the health of participants. Participants’ e-mail ad-
dresses and other data that can be directly traced to
them will be coded with a number so that their privacy
is protected. Non-coded data will be saved separately,
and only the main researchers, the accredited METC,
and Inspectie Gezondheidszorg en Jeugd (IGJ) will have
access to this data file. Data will be kept for a minimum
of 10 years, according to guidelines from the Association
of Universities in the Netherlands (VNSU). Participants
can withdraw from the study at any moment without
consequences. Data gathered from participants up until
their withdrawal will still be used for analyses. No offi-
cial data monitoring committee will be formed, since no
difficulties in data management are anticipated, but use
of a data log, making back-ups of the anonymized data
file, and regularly checking data completeness are several
methods that will be employed to promote data quality.
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Discussion
The aims of the current study are threefold. The first aim
is to investigate the (cost-)effectiveness of the Internet-
based self-help program Featback with and without ex-
pert-patient support. The second aim is to explore predic-
tors, moderators, and mediators of intervention response,
to better understand how and for whom Featback works.
Thirdly, practical experiences with Featback, such as the
intervention usage and user satisfaction, will be examined.
The current study design has several strengths. Firstly,
it is highly similar to a previous RCT from the same re-
search group. Therefore, findings regarding the effective-
ness of Featback can be replicated, and limitations of the
previous study can be overcome. Secondly, cost-effect-
iveness analyses of Internet-based interventions are rare
but very useful in judging which interventions should be
applied over others. Indeed, with ever-declining finances
for health provisions and an increase in desire to offer
effective and inexpensive treatment by health insurances,
cost-effective analyses are indispensable. By conducting
such an analysis, the current study aims to contribute to
economically sensible choices regarding treatment for
individuals with eating-related problems that are found
to be effective as well. Thirdly, the ITT approach used
for data analyses and the multiple imputations used for
handling missing data are solid and recommended
methods. Lastly, the relatively long follow-up period of 1
year helps to more fairly examine the effectiveness of the
different interventions in the long term.
Additionally, some limitations of the current study de-
sign should be noted. Firstly, participants are allowed to
engage in treatment outside of the research for ethical
reasons. Although we will control for healthcare ap-
pointments during the analyses, methodologically it
would be preferable to have all the participants only re-
ceive the experimental intervention. Lastly, only online
measures will be completed by participants. This limits
the diagnostic accuracy, introduces recall bias, and might
reduce intervention usage as well. Indeed, we expect a
fairly high dropout rate, and missing data might not be
at random, which will need to be taken into account
when analyzing the data. Nevertheless, the current ap-
proach is needed to maintain the low threshold and ano-
nymity of the intervention, making it possible to
generalize beyond this study to the real effects of Feat-
back with and without expert-patient support.
The (cost-)effectiveness of Internet-based interven-
tions in combination with expert-patient support for
the (early) interventions of individuals with an ED or
related symptoms has not been investigated before.
Results on this subject will contribute to the delivery
of e-mental health and expert-patient support and
help to guide individuals with eating problems to the
care they need.
Trial registration
This is protocol version number 2, dated 02-28-2019.
Recruitment started 8 October 2018. The approximate
date of recruitment completion is 31 December 2020.
The trial is registered in the Netherlands Trials Register
under number NTR7065.
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Additional file 2: Integrity checklist. (DOCX 23 kb)
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